Mavens Biotech Financials

BSE: 590083

₹0.47

₹-0.02 (-4.08%)

As on 07-Mar-2017IST

Market cap

₹5 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	--	--	--	--	--	--
Total Income	0.06	0.10	0.00	0.01	0.02	0.02
Total Expenditure	0.17	0.16	0.17	0.15	0.15	0.40
EBITDA	-0.17	-0.16	-0.17	-0.15	-0.15	-0.40
Depreciation	--	--	--	--	0.00	0.01
EBIT	-0.17	-0.16	-0.17	-0.15	-0.15	-0.40
Interest	--	--	--	--	--	--
Other Income	0.06	0.10	0.00	0.01	0.02	0.02
Exceptional Items	--	0.11	0.19	--	--	-0.46
Profit before Tax	-0.11	0.04	0.02	-0.14	-0.13	-0.84
Provision for Tax	0.31	--	--	--	--	--
Profit after Tax	-0.42	0.04	0.02	-0.14	-0.13	-0.84

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	5.06	5.47	5.43	5.41	5.55	5.68
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	--	--	--	--
Current Liabilities	0.82	0.39	0.33	0.28	0.31	0.28
Total Liabilities	5.88	5.87	5.76	5.69	5.87	5.96

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	5.64	5.64	5.54	5.42	5.52	5.62
Current Assets	0.24	0.23	0.22	0.28	0.35	0.34
Total Assets	5.88	5.87	5.76	5.69	5.87	5.96
Total Debt*	--	--	--	--	--	--
Net Current Assets	-0.58	-0.17	-0.11	-0.01	0.04	0.06
Contingent Liabilities	3.73	4.04	--	3.79	3.56	3.56

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	0.01	0.04	-0.02	-0.03	0.00	-0.04
Cash Flow from Investing Activities	0.00	--	--	0.01	0.02	0.02
Cash from Financing Activities	--	--	--	--	--	--
Net Cash Inflow / Outflow	0.01	0.04	-0.02	-0.01	0.03	-0.02

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	-0.04	0.00	0.00	-0.01	-0.01	-0.08
Cash EPS (₹)	-0.04	0.00	0.00	-0.01	-0.01	-0.08
Adjusted Book Value (₹)	0.46	0.50	0.49	0.49	0.51	0.52
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	0.00	0.00	0.00	0.00	0.00	0.00
Free Cash Flow per Share (₹)	-0.03	0.01	0.02	0.00	0.00	-0.06

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	-2.04	0.75	0.34	-2.59	-2.29	-13.70
ROE (%)	-7.93	0.75	0.34	-2.59	-2.29	-13.70
ROA (%)	-7.11	0.71	0.32	-2.45	-2.17	-12.38
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-705.92	42.72	1,027.78	-1,233.91	-559.13	-3,632.04
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-1.96	4.84	-11.73	-1.19	62.39	82.03
Net Profit Growth (%)	-1,115.09	122.16	113.04	-10.34	84.61	75.42
EPS Growth (%)	-1,127.03	117.65	113.18	-10.26	84.61	75.42
Book Value Growth (%)	-7.62	0.76	0.34	-2.55	-2.26	-12.82

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-102.01	-163.61	-64.76	-77.29	-85.98	-29.45
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	0.29	0.58	0.67	0.98	1.12	1.23
Quick Ratio	0.29	0.58	0.67	0.98	1.12	1.23
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--